Mr. SHRIYANSH SRIVASTAVA | Pharmacology | Young Scientist Award

Posted on by sciencefather

Mr. SHRIYANSH SRIVASTAVA | Pharmacology | Young Scientist Award 

Mr. SHRIYANSH SRIVASTAVA, Galgotias University , India 🎓

Professional Profile

🌱🎓Early Academic Pursuits

Shriyansh Srivastava embarked on his academic journey with a strong foundation in pharmaceutical sciences. He completed his Bachelor of Pharmacy from Dr. A.P.J. Abdul Kalam Technical University, Lucknow, Uttar Pradesh, India, achieving a commendable 74.82%. His academic prowess continued as he pursued his Master of Pharmacy in Pharmacology at ISF College of Pharmacy, Moga, Punjab, where he maintained an impressive CGPA of 8.54.

👨‍🏫 Professional Endeavors

Currently serving as an Assistant Professor in the School of Medical and Allied Sciences, Department of Pharmacy at Galgotias University, Greater Noida, Uttar Pradesh, India, Shriyansh Srivastava brings his expertise to the forefront of pharmaceutical education. Since August 2021, he has been instrumental in shaping the minds of future pharmacists with a focus on the pharmaceutical field.

📚 Contributions and Research Focus

Shriyansh Srivastava’s research interests span pharmacology and clinical research, particularly focusing on innovative treatments and disease mechanisms. His Master’s thesis titled “Wnt β-Catenin antagonist pyrvinium prevents isoproterenol-induced cardiomyopathy by targeting ATP-sensitive K+ channel,” conducted under the guidance of Dr. Shamsher Singh and Dr. Gaaminepreet Singh at ISF College of Pharmacy, Moga, Punjab, showcases his dedication to advancing pharmaceutical knowledge.

🏆 Accolades and Recognition

His academic contributions are reflected in his publication record and research profiles. Shriyansh Srivastava is actively engaged in scholarly activities, evidenced by his presence on Google Scholar, ResearchGate, Orchid, and Scopus. These platforms highlight his commitment to disseminating research and contributing to the academic community.

🌟 Impact and Influence

As a young academician, Shriyansh Srivastava’s influence extends beyond his teaching role. His research on cardiomyopathy and pharmacological interventions holds promise for advancing treatment options. By mentoring students and participating in academic forums, he continues to inspire future pharmacists and researchers.

🌍 Legacy and Future Contributions

Looking ahead, Shriyansh Srivastava aims to strengthen his technical competence and business acumen over the next three years, contributing to both academic growth and pharmaceutical innovation. His dedication to excellence in teaching and research ensures a lasting impact on the field of pharmacy.

📖Publications Top Noted: 

REMYA P N | Pharmacology, Toxicology and Pharmaceutical Science | Excellence in Innovation

Posted on by sciencefather

Dr. REMYA P N | Pharmacology, Toxicology and Pharmaceutical Science | Excellence in Innovation

SRM Institute of Science and Technology, India

Author Profile

Early Academic Pursuits

Dr. P.N. REMYA embarked on her academic journey with a Bachelor's degree in Pharmacy from S. Chattanatha Karayalar College of Pharmacy, followed by a Master's degree in Pharmaceutics from Arulmigu Kalasalingam College of Pharmacy. Her educational pursuit culminated in a Ph.D. from SRM Institute of Science and Technology, specializing in Pharmaceutics.

Professional Endeavors

Her professional trajectory spans a wealth of teaching experience, from a Tutor post-UG certification to Lecturer roles in various prestigious institutions. Notably, she has been an Associate Professor at SRM College of Pharmacy since October 2018, building upon four years as an Assistant Professor and seven years as a Lecturer in the same institution.

Contributions and Research Focus

Her contributions in academia are multifaceted. She has delved into diverse research projects ranging from sustained-release formulations to topical preparations and nanoparticles. Noteworthy projects include the development of sustained-release Aceclofenac matrix tablets, formulation of bi-layer tablets, and the ongoing research on solid lipid nanoparticles for poorly soluble antihypertensive drugs.

Accolades and Recognition

Her academic prowess is underscored by numerous presentations at national and international conferences, such as the Indian Pharmaceutical Congress and workshops on pharmaceutical technologies and clinical research methodologies. She has also published papers in reputable journals and presented posters on innovative drug delivery systems and formulation strategies.

Impact and Influence

Her impact extends beyond research and teaching. She has actively participated in workshops on quality improvement, pharmacokinetics, and regulatory perspectives, showcasing her commitment to staying abreast of industry trends and fostering a culture of excellence in pharmaceutical education.

Legacy and Future Contributions

As a seasoned educator and researcher, Her legacy lies in her dedication to nurturing future pharmacists and advancing pharmaceutical sciences through cutting-edge research. Her future contributions are poised to further enhance drug delivery systems, formulation technologies, and academic collaborations, ensuring a lasting impact on the field of pharmacy.

Notable Publications 

Formulation and evaluation of bilayered tablets of ibuprofen and methocarbamol

Formulation and evaluation of immediate release tablets of acyclovir

Oral sustained delivery of ranitidine from in-situ gelling sodium-alginate formulation

Formulation, development, and characterization of cilnidipine loaded solid lipid nanoparticles

Formulation, development and characterisation of nimodipine loaded solid lipid nanoparticles

Review on Solid lipid nanoparticles

Formulation and evaluation of fast disintegrating orodispersible tablets of ondansetron hydrochloride

Formulation and pharmacokinetic determination of gallic acid in Emblica Officinalis

Review on Ebola Virus Disease in Clinical and Diagnostic Aspects

Development and Evaluation of Floating in-Situ Gel Solution of Lansoprazole

ROHIT BHATIA | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Posted on by sciencefather

ROHIT BHATIA | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

ISF College of Pharmacy Moga, India

Author Profile

Early Academic Pursuits

Dr. Rohit Bhatia embarked on his academic journey with a B. Pharmacy degree from HP University, graduating with an impressive 75.5% in 2011. Building on this foundation, he pursued a Master's in Pharmacy in Pharmaceutical Chemistry from PTU University, securing a notable 74.5% in 2013. His academic pursuit culminated in a Ph.D. in Pharmaceutical Sciences from MRSPTU, Bathinda, in 2022, showcasing his dedication to advancing in the field.

Professional Endeavors

HIs professional career is marked by significant milestones. He served as an Assistant Professor of Pharmaceutical Chemistry at Laureate Institute of Pharmacy from 2013 to 2016 before transitioning to his current role as an Associate Professor at ISF College of Pharmacy from 2016 to the present. His roles have involved guiding numerous M. Pharm and Ph.D. students, totaling 27 and 3, respectively, showcasing his commitment to mentorship and education in the pharmaceutical field.

Contributions and Research Focus

With a keen interest in drug design and molecular modeling, His contributed significantly to pharmaceutical sciences. His research projects, including the synthesis and evaluation of coumarin fused/tethered nitrogen-containing heterocycles as anticancer agents and work on imidazo [2,1-b] [1,3,4] thiadiazole derivatives, highlight his expertise in synthetic medicinal chemistry and target-based drug design. Furthermore, his focus on analytical method development and bioanalysis, along with microfluidics-based analysis, underscores his multidisciplinary approach to research.

Accolades and Recognition

His contributions have been widely recognized through various grants, awards, and achievements. Notable among these are the MSME grant for developing an electrochemical device for detecting glucose levels in human saliva, received in 2022. His innovative teaching methods earned him the Best Innovative Teacher Award in Pharmaceutical Analysis at the National Pharma Summit-2023. Additionally, he has consistently won prizes and awards for his research presentations, such as the Pharma Rising Star Award and recognition for his work in repurposing drugs against SARS-CoV-2.

Impact and Influence

His work has made a tangible impact on the pharmaceutical landscape, evident from his patents and copyrights. His patents range from techniques for quantifying ascorbic acid to novel drug delivery systems and neuroprotective compounds, showcasing his diverse contributions to the field. Furthermore, his involvement in national and international conferences, along with his role as a Bentham Ambassador, speaks volumes about his influence and standing within the scientific community.

Legacy and Future Contributions

His continues to excel in academia and research, his legacy as a mentor, innovator, and contributor to pharmaceutical sciences is firmly established. His future contributions are anticipated to further push the boundaries of drug design, analytical techniques, and therapeutic innovations. Through his continued dedication to education, research, and impactful collaborations, His  is poised to leave a lasting imprint on the field of pharmaceutical sciences.

Notable Publications 

Synthetic and medicinal perspective of thiazolidinones: A review

Drug metabolizing enzymes and their inhibitors' role in cancer resistance

Inductively coupled plasma optical emission spectrometry (ICP-OES): a powerful analytical technique for elemental analysis

Applications of various analytical techniques in quality control of pharmaceutical excipients

Design, synthesis and neuropharmacological evaluation of new 2, 4-disubstituted-1, 5-benzodiazepines as CNS active agents

Protein tyrosine phosphatase (PTP1B): a promising drug target against life-threatening ailments

based microfluidic devices: Fabrication, detection, and significant applications in various fields

Recent advancements in anti-leishmanial research: Synthetic strategies and structural activity relationships

Enasidenib: first mutant IDH2 inhibitor for the treatment of refractory and relapsed acute myeloid leukemia

Design, synthesis, biological evaluation, and molecular modeling studies of rhodanine derivatives as pancreatic lipase inhibitors